Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
acute myeloid leukemia (AML)
Biotech
Sellas jettisons 2 execs while awaiting ph. 3 cancer vax readout
Chief Commercial Officer Robert Francomano will be departing along with General Counsel and Corporate Secretary Barbara Wood.
Gabrielle Masson
Mar 8, 2024 10:09am
Kura's leukemia drug works best when tacked onto existing combo
Jan 30, 2024 11:15am
Kronos discontinues mid-stage AML trial after poor response
Dec 19, 2023 11:16am
Syros’ stock up after early AML data share
Dec 6, 2023 10:45am
Vor Bio's dual stem cell, ADC shows consistent engraftment
Nov 9, 2023 4:10pm
After 2 partners walk away, Syros cuts 35% of workforce
Oct 2, 2023 11:06am